Sleep Apnea - Treatment improves hypertension;Schlafapnoe - Behandlung verbessert hypertonie

Medizinische Klinik

Volumn 101, Issue 11, 2006, Pages 880-885

  Grotz, Wolfgang ^a,g   Büchner, Nikolaus ^b   Wessendorf, Thomas ^c   Teschler, Helmut ^c   Grote, Ludger ^d   Becker, Heinrich F ^e   Rump, Lars Christian ^f  

^a Alfried Krupp Krankenhaus Essen   (Sweden)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHRLANDKLINIK   (Germany)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY HOSPITAL MARBURG   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g ALFRIED KRUPP KRANKENHAUS   (Germany)

Author keywords

Blood pressure; CPAP; Endothelial dysfunction; Hypertension; Sleep apnea

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BLOOD PRESSURE; BREATHING DISORDER; DAYTIME SOMNOLENCE; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; NECK; PATIENT MONITORING; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP APNEA SYNDROME; SNORING;

CINCLIDAE;

EID: 33846524344     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-006-1117-6     Document Type: Review

References (40)

1. Silverberg DS, Oksenberg A, Iaina A. Sleep related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed, and undertreated. Am J Hypertens 1997;10:1319-25.
2. Silverberg DS, Oksenberg A, Iaina A. Sleep-related breathing disorders as a major cause of essential hypertension: fact or fiction? Curr Opin Nephrol Hypertens 1998;7:353-7.
3. Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984;108:373-6.
4. Kales A, Bixler EO, Cadieux RJ, et al. Sleep apnoea in a hypertensive population. Lancet 1984;2: 1005-8.
5. Fletcher EC, DeBehnke RD, Lovoi MS, et al. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985;103:190-5.
6. Hedner J, Bengtsson-Bostrom K, Peker Y, et al. Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study. Eur Respir J 2006;3:564-70.
7. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
8. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006:28: 596-602.
9. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle aged adults. N Engl J Med 1993;328:1230-5.
10. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165:1217-39.
11. Flemons W, McNicholas W. Likelihood ratios for a sleep apnoe - a clinical prediction rule. Am J Respir Crit Care Med 1994;150:1279-85.
12. Leung RS, Bradley TD. Sleep apnoea and cardiovascular disease. Am J Respir Crit Care Med 2001; 164:2147-65.
13. Davies C, Crosby J, Mullins R, et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000;55:736-40.
14. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479-82.
15. Hu F, Willett W, Colditz G, et al. Prospective study of snoring and risk of hypertension in women. Am J Epidemiol 1999;150:806-16.
16. Nieto F, Young T, Lind B, et al. Association of sleep disordered breathing, sleep apnoea and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829-36.
17. Peppard P, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378-84.
18. Staessen J, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional versus ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999;282:539-46.
19. Morgan T, Brunner H, Aubert J, et al. Cardiac hypertrophy depends on sleep blood pressure: a study in rats. J Hypertens 2000;18:445-51.
20. Ringler J, Basner R, Shannon R, et al. Hypoxemia alone does not explain blood pressure elevations after obstructive apneas. J Appl Physiol 1990;69: 2143-8.
21. Morgan B, Crabtree D, Palta M, et al. Combined hypoxemia and hypercapnea evokes long-lasting sympathetic activations in humans. J Appl Physiol 1995;79:205-13.
22. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-904.
23. Fletcher E, Lesske J, Culma C, et al. Sympathic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 1992;20:612-9.
24. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilatation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607-10.
25. Duchna HW, Guilleminault C, Stoohs RA, et al. Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2000;161: 187-91.
26. Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000;55:1046-51.
27. Phillips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999;17:61-6.
28. Grote L, Kraiczi H, Hedner J. Reduced α- and β-adrenergic response in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000;162: 1480-7.
29. Kraiczi H, Hedner J, Peker Y, et al. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000;89:493-8.
30. Pelttari L, Hietanen E, Salo T, et al. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressare in patients with sleep disordered breathing. Am J Hypertens 1998;11:272-9.
31. Kraiczi H, Hedner J, Peker Y, et al. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000;161:1423-8.
32. Heitmann J, Ehlenz K, Penzel T, et al. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004;23:255-62.
33. Narkiewicz K, Kato M, Phillips BG, et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999;100:2332-5.
34. Ohike Y, Kozaki K, Iijima K, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure. Circ J 2005; 69:221-6.
35. Ip M, Tse H, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004;169: 348-53.
36. Duchna HW, Orth M, Schultze-Werninghaus G, et al. Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome. Sleep Breath 2005;9:97-103.
37. Faccenda J, Mackay T, Boon N, et al. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;163:344-8.
38. Pepperell J, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2001;359:204-10.
39. Becker H, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
40. Logan A, Tkacova R, Perlikowski S, et al. Refractory hypertension and sleep apnea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003;21:241-7.